Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-19

Clinical Trial Update: New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports ongoing research into the role of alpha defensin in metabolic syndrome, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-defensin (alpha-defensin)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Metabolic Syndrome | NA | Status: UNKNOWN